表紙
市場調查報告書

通過戰略業務合作關係改變全球生物銀行市場(2020-2026)

Strategic Commercial Partnerships Transforming the Global Biobanking Market, 2020-2026

出版商 Frost & Sullivan 商品編碼 954127
出版日期 內容資訊 英文 71 Pages
商品交期: 最快1-2個工作天內
價格
通過戰略業務合作關係改變全球生物銀行市場(2020-2026) Strategic Commercial Partnerships Transforming the Global Biobanking Market, 2020-2026
出版日期: 2020年08月12日內容資訊: 英文 71 Pages
簡介

生物銀行生態系統正在發生重大變化。一站式商店和虛擬生物庫的出現,為保持和改善定位而提供的服務的增加以及精密藥品的出現,是特別重大的變化。預計到2020年,全球生物銀行市場的年均複合增長率(CAGR)約為5.2%,到2026年將達到712億美元。歐洲是按地區劃分的最大市場,但預計亞太地區將來會顯著增長。

本報告分析了全球生物銀行市場中技術創新和市場轉型的最新動向,並分析了市場的基本結構,主要利益相關者(利益相關者),主要市場促進和約束因素以及總體市場趨勢(未來7年),按應用,生物庫類型,樣品,所有權類型等劃分的詳細趨勢,以及技術開發和推廣的最新趨勢以及未來趨勢我們正在考慮市場機遇和挑戰。

目錄

戰略問題

  • 為什麼成長越來越困難?
  • "Strategic Imperative 8" (TM)
  • 對生物銀行業五個主要戰略挑戰的影響
  • Strategic Imperative 8(TM)促進增長機會

增長機會分析:生物銀行市場

  • 生物銀行市場:分析範圍
  • 生物銀行市場:分析範圍-新冠狀病毒感染(COVID-19)的影響
  • 生物銀行市場:分析範圍-主要市場主題
  • 生物銀行市場:分析範圍-價值鍊和主要利益相關者
  • 生物銀行市場:分析範圍-工作流程優化
  • 生物銀行市場:分析範圍-生物銀行的未來作用
  • 生物銀行市場細分
  • 生物銀行市場的領導者和最終用戶
  • 生物銀行市場的關鍵增長指標
  • 促進生物銀行市場的因素
  • 限制生物銀行市場的因素
  • 市場預測假設
  • 生物銀行市場:市場收入預測
  • 生物銀行市場:按地區劃分的市場收入預測
  • 按應用劃分的市場利潤預測
  • 按應用劃分的市場收入份額預測
  • 按生物庫類型劃分的市場利潤預測
  • 按生物庫類型劃分的市場收入份額預測
  • 按樣本類型劃分的市場收入預測
  • 按樣本類型劃分的市場收入份額預測
  • 按所有權類型劃分的市場利潤預測
  • 按所有權類型劃分的市場收入份額預測
  • 利益相關者的參與,生物銀行市場
  • 價格分析,生物銀行市場
  • 最終用戶分析,生物銀行市場
  • 競爭環境,生物銀行市場

市場增長機會:生物銀行市場

  • 五個主要增長機會
  • 增長機會(1):共同開發基於生物標記物療法的伴隨診斷程序(2020)
  • 增長機會(2):大規模基因組序列分析項目的生物數據(2020)
  • 增長機會(3):用於腫瘤學臨床發展的人體組織/腫瘤細胞(2020)
  • 增長機會(4):數位病理學和圖像處理服務(2020)
  • 增長機會(5):產品商業化的RWE(真實證據)分析(2020)

下一步

目錄
Product Code: MFA8-52

Precision Medicine Applications and Value-based Data Pricing with Pharma and Health-tech to Trigger Market Growth

The biobanking ecosystem is witnessing significant transformation. Emergence of one-stop shops and virtual biobanks, rise in services offered to sustain and improve positioning, and precision medicine are characterizing this transformative environment. The biobanking market is expected to reach a size of ~$71.2 billion by 2026, registering a compound annual growth rate (CAGR) of ~5.2% from 2020. While Europe is the highest contributor to the total market, Asia-Pacific (APAC) is expected to witness the highest growth during the forecast period (2020 to 2026) of this research. This market will be driven further by innovation in targeted therapeutic applications, high sample utilization of tissue/stem cells, and the increasing demand for bio-data for enabling patient stratification. Significant growth opportunities for biobanks are in the areas of companion diagnostics (CDx) co-development, large-scale genome sequencing projects, immuno-oncology clinical development, digital pathology services, and real-world evidence (RWE) studies.

The shifting industry paradigm towards commercial partnerships with pharmaceutical and biotech companies, contract research organizations (CROs), and contract development and manufacturing organizations (CDMOs), as well as diagnostics and digital solution providers is expected to further boost market growth. Biobanks are partnering with end-users for customized research-based engagements as niche providers of samples and services and as data owners. However, they need to better understand the changing end-user needs and transition to innovative value-based data pricing and hybrid models for ensuring operational sustainability in the future. Collaborations with commercial partners by fulfilling key selection criteria and engaging with well-defined models are a critical requirement for biobanks to retain market share. A number of leading biobanks in the United States, the United Kingdom, Sweden, and Denmark have taken major strides in adopting and implementing industry best practices in the last few years.

Table of Contents

Strategic Imperatives

  • Why Is It Increasingly Difficult to Grow?
  • The Strategic Imperative 8™
  • The Impact of the Top Five Strategic Imperatives on the Biobanking Industry
  • The Impact of the Top Five Strategic Imperatives on the Biobanking Industry (continued)
  • Growth Opportunities Fuel the Growth Pipeline Engine™

Growth Opportunity Analysis, Biobanking Market

  • Biobanking Market, Scope of Analysis
  • Biobanking Market, Scope of Analysis (continued)
  • Biobanking Market, Scope of Analysis-COVID-19 Impact
  • Biobanking Market, Scope of Analysis-Key Market Themes
  • Biobanking Market, Scope of Analysis-Value Chain & Key Stakeholders
  • Biobanking Market, Scope of Analysis-Workflow Optimization
  • Biobanking Market, Scope of Analysis-Future Role of Biobanks
  • Biobanking Market, Scope of Analysis-Future Role of Biobanks (continued)
  • Biobanking Market, Scope of Analysis-Future Role of Biobanks (continued)
  • Biobanking Market, Segmentation
  • Key Competitors and End-users in the Biobanking Market
  • Key Growth Metrics for the Biobanking Market
  • Growth Drivers for the Biobanking Market
  • Growth Driver Analysis for the Biobanking Market
  • Growth Driver Analysis for the Biobanking Market (continued)
  • Growth Restraints for the Biobanking Market
  • Growth Restraint Analysis for the Biobanking Market
  • Market Forecast Assumptions, Methodology-Biobanking Market
  • Revenue Forecast, Biobanking Market
  • Revenue Forecast Analysis by Region, Biobanking Market
  • Revenue Forecast Analysis by Region, Biobanking Market (continued)
  • Revenue Forecast Analysis by Region, Biobanking Market (continued)
  • Revenue Forecast Analysis by Region, Biobanking Market (continued)
  • Revenue Forecast Analysis by Region, Biobanking Market (continued)
  • Revenue Forecast Analysis by Region, Biobanking Market (continued)
  • Revenue Forecast by Application
  • Percent Revenue Share by Application
  • Revenue Forecast by Biobank Type
  • Percent Revenue Share by Biobank Type
  • Revenue Forecast by Sample Type
  • Percent Revenue Share by Sample Type
  • Revenue Forecast by Ownership Type
  • Percent Revenue Share by Ownership Type
  • Stakeholder Engagement, Biobanking Market
  • Pricing Analysis, Biobanking Market
  • Pricing Analysis, Biobanking Market (continued)
  • End-user Analysis, Biobanking Market
  • Competitive Environment, Biobanking Market
  • Competitive Environment, Biobanking Market (continued)
  • Competitive Environment, Biobanking Market (continued)
  • Competitive Environment, Biobanking Market (continued)
  • Competitive Environment, Biobanking Market (continued)

Growth Opportunity Universe, Biobanking Market

  • Top 5 Growth Opportunities
  • Growth Opportunity 1: Companion Diagnostics Co-Development for Biomarker-based Therapeutics, 2020
  • Growth Opportunity 1: Companion Diagnostics Co-Development Analysis, 2020
  • Growth Opportunity 2: Bio-data for Large-scale Genome Sequencing Projects, 2020
  • Growth Opportunity 2: Large-scale Genome Sequencing Analysis, 2020
  • Growth Opportunity 3: Human Tissue/Tumor Cells for Oncology Clinical Development, 2020
  • Growth Opportunity 3: Oncology Clinical Development Analysis, 2020
  • Growth Opportunity 4: Digital Pathology and Imaging Services, 2020
  • Growth Opportunity 4: Digital Pathology and Imaging Analysis, 2020
  • Growth Opportunity 5: RWE Studies for Product Commercialization, 2020
  • Growth Opportunity 5: RWE Analysis, 2020

Next Steps

  • Your Next Steps
  • Why Frost, Why Now?
  • List of Exhibits
  • Legal Disclaimer